Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study.

PubWeight™: 9.43‹?› | Rank: Top 0.1%

🔗 View Article (PMID 9521222)

Published in Arch Intern Med on March 23, 1998

Authors

M D Silverstein1, J A Heit, D N Mohr, T M Petterson, W M O'Fallon, L J Melton

Author Affiliations

1: Department of Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minn 55905, USA.

Associated clinical trials:

Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events (GARFIELD-VTE) | NCT02155491

EXercise Training for the Prevention of Cancer Thrombosis (EXPECT) Pilot Trial (EXPECT) | NCT01853202

Incidence and Outcomes of Venous Thromboembolism | NCT00005351

Articles citing this

(truncated to the top 100)

Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol (2012) 4.47

A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med (2009) 4.46

Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood (2008) 4.06

Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med (2012) 3.63

The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol (2008) 3.50

Pulmonary embolism: the weekend effect. Chest (2012) 2.89

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76

Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut (2004) 2.55

Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med (2005) 2.51

Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 2.50

Venous thromboembolism in the outpatient setting. Arch Intern Med (2007) 2.46

Physical inactivity and idiopathic pulmonary embolism in women: prospective study. BMJ (2011) 2.34

Clinical utility of D-dimer in patients with suspected pulmonary embolism and nondiagnostic lung scans or negative CT findings. Chest (2004) 2.30

The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med (2006) 2.21

Air travel and venous thromboembolism: a systematic review. J Gen Intern Med (2007) 2.21

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thromb J (2013) 2.21

Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003-2008. Am J Obstet Gynecol (2012) 2.03

Epidemiology and risk factors for venous thrombosis. Semin Hematol (2007) 1.90

Pulmonary embolism incidence is increasing with use of spiral computed tomography. Am J Med (2008) 1.82

Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol (2007) 1.80

Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma. Blood (2008) 1.78

Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study. J Thromb Thrombolysis (2009) 1.71

Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis. BMJ (2013) 1.70

American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med (2001) 1.70

Variation in thromboembolic complications among patients undergoing commonly performed cancer operations. J Vasc Surg (2012) 1.65

Pulmonary embolism: is multislice CT the method of choice? For. Eur J Nucl Med Mol Imaging (2005) 1.60

Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer. Br J Cancer (2007) 1.60

Validation of two age dependent D-dimer cut-off values for exclusion of deep vein thrombosis in suspected elderly patients in primary care: retrospective, cross sectional, diagnostic analysis. BMJ (2012) 1.54

Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism - the J-EINSTEIN DVT and PE program. Thromb J (2015) 1.51

Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcif Tissue Int (2011) 1.50

Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice. J Thromb Haemost (2015) 1.46

Diagnosis and treatment of deep-vein thrombosis. CMAJ (2006) 1.44

Thromboembolic complications of sling surgery for stress urinary incontinence among female Medicare beneficiaries. Urology (2009) 1.41

Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies. J Cancer Res Clin Oncol (2009) 1.38

Rethinking guidelines for VTE risk among nursing home residents: a population-based study merging medical record detail with standardized nursing home assessments. Chest (2014) 1.37

Clinical features from the history and physical examination that predict the presence or absence of pulmonary embolism in symptomatic emergency department patients: results of a prospective, multicenter study. Ann Emerg Med (2010) 1.37

Patient outcomes after deep vein thrombosis and pulmonary embolism: the Worcester Venous Thromboembolism Study. Arch Intern Med (2008) 1.36

The Prophylaxis of Venous Thromboembolism. Dtsch Arztebl Int (2016) 1.36

Is diabetes mellitus an independent risk factor for venous thromboembolism?: a population-based case-control study. Arterioscler Thromb Vasc Biol (2009) 1.34

Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? Arthritis Rheum (2012) 1.34

Prospective evaluation of unsuspected pulmonary embolism on contrast enhanced multidetector CT (MDCT) scanning. Thorax (2006) 1.33

Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study. BMJ (2011) 1.33

New insights into the mechanisms of venous thrombosis. J Clin Invest (2012) 1.32

Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism. Patient Prefer Adherence (2010) 1.26

Review: thromboses among HIV-infected patients during the highly active antiretroviral therapy era. AIDS Patient Care STDS (2008) 1.20

Correlates and consequences of venous thromboembolism: The Iowa Women's Health Study. Am J Public Health (2009) 1.18

Deep vein thrombosis: a clinical review. J Blood Med (2011) 1.15

Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study. Blood (2011) 1.14

Prospective study of BMI and the risk of pulmonary embolism in women. Obesity (Silver Spring) (2009) 1.14

Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism. J Gen Intern Med (2000) 1.13

Prevention of venous thromboembolism in spinal surgery. Eur Spine J (2003) 1.12

Dots are not clots: the over-diagnosis and over-treatment of PE. Emerg Radiol (2010) 1.11

Upper extremity deep vein thrombosis: a community-based perspective. Am J Med (2007) 1.11

Accuracy in diagnosing deep and pelvic vein thrombosis in primary care: an analysis of 395 cases seen by 58 primary care physicians. Dtsch Arztebl Int (2012) 1.10

Role of tissue factor in venous thrombosis. Annu Rev Physiol (2011) 1.09

Venous thromboembolism and bleeding in a community setting. The Worcester Venous Thromboembolism Study. Thromb Haemost (2009) 1.09

Healthcare disparities in critical illness. Crit Care Med (2013) 1.08

Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients. Thromb Haemost (2013) 1.08

Epidemiology of venous thromboembolism. Nat Rev Cardiol (2015) 1.07

Postdischarge thromboprophylaxis and mortality risk after hip-or knee-replacement surgery. CMAJ (2008) 1.07

High-density lipoprotein cholesterol and venous thromboembolism in the Longitudinal Investigation of Thromboembolism Etiology (LITE). Blood (2008) 1.07

A population-based study of inferior vena cava filters in patients with acute venous thromboembolism. Arch Intern Med (2010) 1.04

Venous thromboembolism prophylaxis after head and spinal trauma: intermittent pneumatic compression devices versus low molecular weight heparin. World J Surg (2004) 1.03

Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations. Arthritis Rheum (2006) 1.02

Pulmonary embolism incidence and fatality trends in chinese hospitals from 1997 to 2008: a multicenter registration study. PLoS One (2011) 1.02

Cancer-related coagulopathy (Trousseau's syndrome): review of the literature and experience of a single center of internal medicine. Clin Exp Med (2013) 1.01

MR Venography for the Assessment of Deep Vein Thrombosis in Lower Extremities with Varicose Veins. Ann Vasc Dis (2014) 1.00

The epidemiology of venous thromboembolism. J Thromb Thrombolysis (2016) 1.00

Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials. PLoS Med (2012) 0.99

Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study. Osteoporos Int (2004) 0.99

Venous thromboembolism in the elderly. A community-based perspective. Thromb Haemost (2008) 0.99

Hospital-level variation in ICU admission and critical care procedures for patients hospitalized for pulmonary embolism. Chest (2014) 0.99

Acute right ventricular failure in the setting of acute pulmonary embolism or chronic pulmonary hypertension: a detailed review of the pathophysiology, diagnosis, and management. Curr Cardiol Rev (2008) 0.98

A more aggressive approach to emergency embolectomy for acute pulmonary embolism. Mayo Clin Proc (2010) 0.98

Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. Thromb Res (2007) 0.98

Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009). Am J Med (2014) 0.98

The prothrombotic phenotypes in familial protein C deficiency are differentiated by computational modeling of thrombin generation. PLoS One (2012) 0.97

Incidence of Deep Vein Thrombosis and Pulmonary Embolism in the Elective Pediatric Orthopaedic Patient. J Pediatr Orthop (2016) 0.97

Pulmonary embolism in patients with CKD and ESRD. Clin J Am Soc Nephrol (2012) 0.96

Clinical update on pulmonary embolism. Arch Med Sci (2013) 0.96

Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study. Thromb Res (2010) 0.96

Snoring and the risk of obstructive sleep apnea in patients with pulmonary embolism. Sleep (2010) 0.96

Risk factors and underlying mechanisms for venous stasis syndrome: a population-based case-control study. Vasc Med (2009) 0.96

Haematology and neurology. J Neurol Neurosurg Psychiatry (2007) 0.96

Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study. Blood (2010) 0.96

Hydrogen peroxide promotes aging-related platelet hyperactivation and thrombosis. Circulation (2013) 0.95

Treatment options for venous thromboembolism: lessons learnt from clinical trials. Thromb J (2014) 0.95

Hormonal contraception and thrombotic risk: a multidisciplinary approach. Pediatrics (2011) 0.94

Diet and incident venous thromboembolism: the Iowa Women's Health Study. Am Heart J (2009) 0.94

Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study. Blood (2014) 0.94

Risk of site-specific cancer in incident venous thromboembolism: a population-based study. Thromb Res (2014) 0.94

Genetics University of Toronto Thrombophilia Study in Women (GUTTSI): genetic and other risk factors for venous thromboembolism in women. Curr Control Trials Cardiovasc Med (2001) 0.93

Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients. Br J Cancer (2009) 0.93

Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline. Can Respir J (2010) 0.92

Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications. Osteoporos Int (2012) 0.91

Incidence of deep vein thrombosis after major lower limb orthopedic surgery: analysis of a nationwide claim registry. Yonsei Med J (2015) 0.91

Do neutrophil extracellular traps contribute to the heightened risk of thrombosis in inflammatory diseases? World J Cardiol (2015) 0.90

Evolving use of new oral anticoagulants for treatment of venous thromboembolism. Blood (2014) 0.90

Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjects. Eur J Clin Pharmacol (2003) 0.90

Magnetic resonance imaging of acute pulmonary embolism. Eur Radiol (2007) 0.89

Articles by these authors

Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet (2003) 11.91

The diagnosis of osteoporosis. J Bone Miner Res (1994) 10.90

Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med (1994) 9.25

Hip fractures in the elderly: a world-wide projection. Osteoporos Int (1992) 9.08

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51

Involutional osteoporosis. N Engl J Med (1986) 8.20

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med (2000) 7.62

Psychotropic drug use and the risk of hip fracture. N Engl J Med (1987) 7.53

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44

The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone (1995) 5.76

Prevention of venous thromboembolism. Chest (2001) 5.59

Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54

Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med (1990) 5.49

Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) (1982) 5.29

A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. Am Rev Respir Dis (1992) 5.22

Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA (1996) 5.17

A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92

Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology (1992) 4.84

Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res (1992) 4.75

Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 4.74

Population-based study of survival after osteoporotic fractures. Am J Epidemiol (1993) 4.71

Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology (2007) 4.28

Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab (1998) 4.28

A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res (1998) 4.24

Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med (1992) 4.19

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18

Surgical management of Meckel's diverticulum. An epidemiologic, population-based study. Ann Surg (1994) 4.16

Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke (1996) 4.13

Potential effect of authorization bias on medical record research. Mayo Clin Proc (1999) 4.01

Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology (1991) 3.90

The prevention and treatment of osteoporosis. N Engl J Med (1992) 3.90

Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. N Engl J Med (1982) 3.77

Lymphoid neogenesis in rheumatoid synovitis. J Immunol (2001) 3.63

The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol (2000) 3.62

Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest (1981) 3.60

Carpal tunnel syndrome in Rochester, Minnesota, 1961 to 1980. Neurology (1988) 3.40

Thoracic aortic aneurysms: a population-based study. Surgery (1982) 3.36

Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc (1990) 3.34

Epidemiology of vertebral fractures in women. Am J Epidemiol (1989) 3.27

Perturbation of the T-cell repertoire in patients with unstable angina. Circulation (1999) 3.20

The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol (1980) 3.19

Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08

Epidemiology of cervical radiculopathy. A population-based study from Rochester, Minnesota, 1976 through 1990. Brain (1994) 3.07

Incidence of spontaneous pneumothorax in Olmsted County, Minnesota: 1950 to 1974. Am Rev Respir Dis (1979) 3.06

T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A (2000) 3.06

Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int (2011) 3.04

Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood (1993) 2.98

Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum (1999) 2.98

Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med (1999) 2.98

Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest (2000) 2.94

Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation (1989) 2.94

Epidemiology of fractures of the proximal femur in Rochester, Minnesota. Clin Orthop Relat Res (1981) 2.93

Standardized problem list generation, utilizing the Mayo canonical vocabulary embedded within the Unified Medical Language System. Proc AMIA Annu Fall Symp (1997) 2.93

Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest (1982) 2.92

Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89

Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum (1984) 2.85

Fracture incidence in Olmsted County, Minnesota: comparison of urban with rural rates and changes in urban rates over time. Osteoporos Int (1999) 2.83

Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood (1992) 2.81

Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc (1999) 2.80

Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med (1986) 2.80

Epidemiologic features of humeral fractures. Clin Orthop Relat Res (1982) 2.79

Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int (1979) 2.79

Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence. Stroke (2000) 2.78

Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol (2001) 2.78

Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med (2000) 2.77

Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75

Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int (2008) 2.74

Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int (2008) 2.72

Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation (1999) 2.71

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol (1999) 2.69

Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch Dermatol (2000) 2.68

Intercessory prayer and cardiovascular disease progression in a coronary care unit population: a randomized controlled trial. Mayo Clin Proc (2001) 2.61

Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res (1993) 2.59

Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke (1999) 2.56

Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota. Mayo Clin Proc (1995) 2.55

Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol (1992) 2.54

The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis Rheum (1999) 2.50

Long-term survival of a cohort of community residents with asthma. N Engl J Med (1994) 2.47

Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? Ann Rheum Dis (2007) 2.46

Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab (2001) 2.43

Emotional responses of athletes to injury. Mayo Clin Proc (1990) 2.43

Accuracy of the death certificate in a population-based study of asthmatic patients. JAMA (1993) 2.42